ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,943Medicare Part D Prescriptions Filled, Including Refills

Rank: 1069 out of 3647

$652K Total Retail Price of All Prescriptions

Rank: 643 out of 3647

426 Patients Receiving at Least One Drug in Part D
94%Patients 65 Years and Older
46% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

7% of this provider’s 426 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

1% of this provider’s 8,466 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$73 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
LEVOTHYROXINE SODIUM 497 462 1 5
SIMVASTATIN 447 421 2 1
WARFARIN SODIUM 306 276 3 15
FUROSEMIDE 304 279 4 8
OMEPRAZOLE 271 254 5 3
POTASSIUM CHLORIDE 251 217 6 24
TRAMADOL HCL 197 192 7 22
AMLODIPINE BESYLATE 183 176 8 2
CRESTOR 176 172 9 19
METOPROLOL TARTRATE 149 145 10 7
FLUTICASONE PROPIONATE 136 131 11 32
NAMENDA 130 130 12 49
ATENOLOL 127 105 13 10
ALLOPURINOL 124 119 14 37
METOPROLOL SUCCINATE 124 123 14 18
DONEPEZIL HCL 121 121 16 30
CITALOPRAM HBR 116 115 17 25
ALBUTEROL SULFATE 110 110 18 157
ZOLPIDEM TARTRATE 105 104 19 14
ATORVASTATIN CALCIUM 99 99 20 13
MIRTAZAPINE 88 87 21 63
PANTOPRAZOLE SODIUM 88 86 21 38
GABAPENTIN 86 86 23 17
HYDROCODONE-ACETAMINOPHEN 85 65 S3 24 12
MELOXICAM 78 78 25 33
DIOVAN HCT 76 76 26 80
LISINOPRIL 73 65 27 4
DIGOXIN 72 72 28 51
NEXIUM 71 66 29 44
EXELON 69 69 30 129
DIOVAN 69 64 30 40
ISOSORBIDE MONONITRATE ER 68 68 32 56
TAMSULOSIN HCL 66 66 33 28
AZITHROMYCIN 65 62 34 34
CYMBALTA 61 54 35 79
CELEBREX 59 59 36 111
POLYETHYLENE GLYCOL 3350 59 59 36 143
IPRATROPIUM-ALBUTEROL 57 57 38 150
METFORMIN HCL ER 57 23 38 92
SERTRALINE HCL 56 56 40 27
GLIMEPIRIDE 55 43 41 45
LOSARTAN-HYDROCHLOROTHIAZIDE 54 49 42 48
TRIAMTERENE-HCTZ 50 45 43 58
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 27, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.